ArticleAntimicrobial agents and chemotherapy2021

Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model.

Miao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.